Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDTenax Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 3 | -$0.74 | -$0.08 | -$0.41 |
| Q2 2025 | 2 | -$0.44 | -$0.44 | -$0.44 |
| Q3 2025 | 2 | -$1.06 | -$1.06 | -$1.06 |
| Q4 2025 | 2 | -$1.35 | -$1.35 | -$1.35 |
| Q1 2026 | 1 | -$0.23 | -$0.23 | -$0.23 |
| Q2 2026 | 1 | -$0.24 | -$0.24 | -$0.24 |
| Q3 2026 | 1 | -$0.23 | -$0.23 | -$0.23 |
| Q4 2026 | 1 | -$0.24 | -$0.24 | -$0.24 |
| Q1 2027 | 1 | -$0.24 | -$0.24 | -$0.24 |
| Q2 2027 | 1 | -$0.24 | -$0.24 | -$0.24 |
| Q3 2027 | 1 | -$0.26 | -$0.26 | -$0.26 |
| Q4 2027 | 1 | -$0.27 | -$0.27 | -$0.27 |
Tenax Therapeutics, Inc. Earnings Date And Information
Tenax Therapeutics, Inc. last posted its earnings results on Tuesday, March 25th, 2025. The company reported $-0.18 earnings per share for the quarter, topping analysts' consensus estimates of $-0.52 by $0.34. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Tenax Therapeutics, Inc. has generated $0 earnings per share over the last year ($-0.12 diluted earnings per share) and currently has a price-to-earnings ratio of -4.63. Tenax Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 12th, 2025 based on prior year's report dates.
Tenax Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/25/2025 | Q4 2024 | -$0.52 | $0.00 | N/A | $0 | $0 |
| 11/13/2024 | Q3 2024 | -$1.38 | -$0.19 | 1.19 | $0 | $0 |
| 08/13/2024 | Q2 2024 | -$1.99 | -$1.83 | 0.16 | $0 | $0 |
| 05/14/2024 | Q1 2024 | -$2.40 | $3.12 | 5.52 | N/A | $0 |
| 03/28/2024 | Q4 2023 | -$8.14 | -$10.81 | -2.67 | N/A | $5,790 |
| 11/13/2023 | Q3 2023 | -$7.20 | -$6.61 | 0.59 | N/A | $0 |
| 08/14/2023 | Q2 2023 | -$0.10 | -$4.00 | -3.9 | N/A | $0 |
| 05/15/2023 | Q1 2023 | -$0.37 | -$37.44 | -37.07 | N/A | $0 |
| 03/30/2023 | Q4 2022 | N/A | -$101.79 | N/A | N/A | $0 |
| 11/10/2022 | Q3 2022 | -$176.00 | -$531.76 | -355.76 | N/A | $0 |
| 08/11/2022 | Q2 2022 | -$144.00 | -$544.87 | -400.87 | N/A | $0 |
| 05/16/2022 | Q1 2022 | -$144.00 | -$518.07 | -374.07 | N/A | $0 |
| 03/29/2022 | Q4 2021 | N/A | -$214.04 | N/A | N/A | $0 |
| 11/15/2021 | Q3 2021 | N/A | -$241.18 | N/A | N/A | $0 |
| 08/16/2021 | Q2 2021 | -$0.13 | -$159.56 | -159.43 | N/A | $0 |
| 05/17/2021 | Q1 2021 | -$336.00 | -$2,618.03 | -2282.03 | N/A | $0 |
| 03/31/2021 | Q4 2020 | -$288.00 | -$282.98 | 5.02 | N/A | $0 |
| 11/16/2020 | Q3 2020 | -$208.00 | -$285.88 | -77.88 | N/A | $0 |
| 08/14/2020 | Q2 2020 | N/A | -$367.75 | N/A | N/A | $0 |
| 05/15/2020 | Q1 2020 | -$0.19 | -$609.14 | -608.95 | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Tenax Therapeutics, Inc. Earnings: FAQ's
Tenax Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 12th, 2025 based offlast year's report dates.
In the previous quarter, Tenax Therapeutics, Inc. (:TENX) reported $-0.18 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.52 by $0.34.
The conference call for Tenax Therapeutics, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Tenax Therapeutics, Inc.'s latest earnings report can be read online.
Tenax Therapeutics, Inc. (:TENX) has a recorded net income of $-17,602,000.Tenax Therapeutics, Inc. has generated $-0.12 earnings per share over the last four quarters.
Tenax Therapeutics, Inc. (:TENX) has a price-to-earnings ratio of -4.63 and price/earnings-to-growth ratio is -0.04.